Benjamin completed his undergraduate degree in Biological Sciences at the University of Oxford. He was then accepted onto the prestigious Wellcome Trust PhD Studentship for Developmental Biology at the University of Cambridge. He is now strengthening his business knowledge through active engagement with the Accelerate Programme at the Cambridge Judge Business School. This makes him an ideal candidate to communicate the science and the business to potential investors and buyers, in addition to his scientific role within the company.
Dr Benjamin Shaw, CEO
Dr Gustavo Cerda-Moya, CTO and inventor
Gustavo completed his PhD at the University of Cambridge in the field of molecular biology. He then went on to do a successful Post-doc also at the University of Cambridge. Using his knowledge of molecular biology, he discovered a revolutionary method of detecting DNA. He now works full time for Swift Molecular Diagnostics.
Barry has developed many medical diagnostic and imaging companies from an early stage. He brings experience to the team and provides mentorship and introductions to move this exciting company forward. He was the Group Executive for Corporate Strategy and Research at Dalgety plc, the largest food and agriscience company in the UK. He was invited to work for the NHS Innovation Health and Wealth initiative, encouraging the Hospital Trusts and Clinical Commissioning Groups to adopt bolder approaches to innovation. He is ideally placed to guide this passionate team to business success.
Sam Hussain, Business Strategy
Sam is a former management consultant who is now working with early-stage startups. After graduating with a Masters in Engineering from Oxford, he spent three and a half years as a consultant at Oliver Wyman. While he was there, he worked on strategy projects including writing business cases, financial modelling, market entry strategies and assessing growth and m&a opportunities. He has worked for a range of corporates and investment funds in the UK, Europe and Middle East. Sam now operates as a key member of the team, helping produce business models and financial forecasts.
Professor Anne Ferguson-Smith, Advisory board
Anne Ferguson-Smith is Professor of Genetics and the head of the Genetics Department at the University of Cambridge. She received her Ph.D. from the Department of Biology at Yale University. For the past two decades, her team has studied genomic imprinting in development and disease and the epigenetic control of genome function in a wider context. She is a Wellcome Senior Investigator, elected member of EMBO and a Fellow of the Academy of Medical Sciences. Anne has a fantastic academic reputation; as such, she is ideally placed to assess the quality of the technology and advise the scientific progression of the company.